Ceradyne's Q4 2008 earnings call reveals significant short-term headwinds, particularly in body armor sales and reduced guidance for 2009.  Lowered revenue forecasts and concerns over delays in XSAPI contracts, combined with ongoing issues in European markets, suggest a negative impact on stock price.  However, management highlights strong liquidity and potential for growth in non-defense sectors, like solar ceramics, potentially mitigating the overall negative outlook.

[-1]
